1. Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2′-fluoro-1,1′-biphenyl-4-yl)-3-methyl-4-quinolinecarboxylic acid sodium salt] against experimental tumors;Dexter;Cancer Res,1985
2. Mechanism of action of the novel anticancer agent 6-fluoro-2-(2′-fluoro-1,1′-biphenyl-4-yl)-3-methyl-4-quinolinecarboxylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis;Chen;Cancer Res,1986
3. Inhibition of pyrimidine de novo synthesis by DUP-785 (NSC 368390);Peters;Invest New Drugs,1987
4. Roed H, Vindeløv L, Jensen PB, Christensen IJ, Hansen HH. In vitro evaluation of a novel 4-quinolinecarboxylic acid, DUP-785 (NSC 368 390) against human small cell lung cancer cell lines. Eur J Cancer Clin Oncol (submitted).
5. Phase I study of DUP-785 (NSC 368390) in solid tumors;Joggi,1988